Charles River Laboratories International, Inc. (CRL) is a publicly traded Healthcare sector company. As of May 20, 2026, CRL trades at $156.24 with a market cap of $7.22B and a P/E ratio of -41.91. CRL moved +2.47% today. Year to date, CRL is -25.10%; over the trailing twelve months it is +8.71%. Its 52-week range spans $91.86 to $230.02. Analyst consensus is buy with an average price target of $205.38. Rallies surfaces CRL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Charles River Laboratories International, Inc. (CRL) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. CRL moved +2.47% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $156.24 |
| Market Cap | $7.22B |
| P/E Ratio | -41.91 |
| EPS | $-3.70 |
| Dividend Yield | 0.00% |
| 52-Week High | $230.02 |
| 52-Week Low | $91.86 |
| Volume | 747.46K |
| Avg Volume | 0 |
| Revenue (TTM) | $4.03B |
| Net Income | $-182.84M |
| Gross Margin | 0.00% |
10 analysts cover CRL: 0 strong buy, 7 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $205.38.